Delivery Order SPE2DB20D3101-SPE2DB23FRTM7

Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,016.65 firm fixed-price delivery order is for the pharmaceutical product EMVERM 100 MG TABLET CHEW UDS. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order worth $3,958.80 for the delivery of EMVERM 100 MG TABLET CHEW UDS medical supplies. The contract has an ultimate completion date of September 29, 2023 and is a Firm Fixed Price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,051.18 firm fixed-price contract is for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with an ultimate completion date of February 27, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,275.38 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $15,452.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product, with a completion date of January 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside designation, indicating open competition....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $19,013.28 firm fixed price contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,189.79 fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has a ceiling value of $6,189.79 and a completion date of July 24, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,624.71 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,613.24, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a medication, with a ceiling value of $5,746.84 and a period of performance through October 8, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRTM7
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,074.41, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of August 3, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a for-profit organization that is registered in the System for Award Management (SAM.gov) and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 11:34 AM